SMTI - Sanara MedTech Inc.
Other OTC - Other OTC Delayed Price. Currency in USD
Sanara MedTech Inc.
1200 Summit Avenue
Suite 414
Fort Worth, TX 76102
United States
817-529-2300
http://www.wndm.com
Sector: Healthcare
Industry: Medical Care
Full Time Employees: 19
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. J. Michael Carmena | Vice Chairman & Principal Exec. Officer | 207.11k | N/A | 1956 |
| Mr. Michael D. McNeil | Chief Financial Officer | 178.76k | N/A | 1966 |
| Mr. Ronald T. Nixon | Exec. Chairman | N/A | N/A | 1956 |
| Mr. Callon Nichols | Director of Investor Relations | N/A | N/A | N/A |
| Dr. Jane A. Fore | Chief Medical Officer | N/A | N/A | N/A |
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Description
Sanara MedTech Inc. develops, markets, and distributes biotechnology products to physicians, hospitals, and clinics in the United States. It offers HemaQuell, a resorbable bone hemostat for bone healing; and CellerateRX surgical for healing. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was founded in 1982 and is based in Fort Worth, Texas.
Corporate Governance
Sanara MedTech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.